MULLICA HILL, N.J.–(BUSINESS WIRE)–#Cornea–Dr. Paul Karpecki Named Lead Optometric Advisor for OcuMedic, Inc.; leading corneal health researcher to assume key role on Company’s SAB
Author: Business Wire
2018 Innovations in Drug Delivery, Cancer Immunotherapies, Biomarker Identification, and Gene Therapy for Preventing Vision Loss – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Innovations in Drug Delivery, Cancer Immunotherapies, Biomarker Identification, and Gene Therapy for Preventing Vision Loss” report has been added to ResearchAndMarkets.com’s offering. This Genetic Technology TOE depicts l…
2018 Innovations in Hydrogen Production, Neural Cell Implants, Solar Panel Recycling, Artificial Intelligence, and Ophthalmology – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Innovations in Hydrogen Production, Neural Cell Implants, Solar Panel Recycling, Artificial Intelligence, and Ophthalmology” report has been added to ResearchAndMarkets.com’s offering. This edition of the Inside R&D TOE de…
Novaliq to Present at the Ophthalmology Futures Forums on How to Break the Vicious Circle of Dry Eye Disease
HEIDELBERG, Germany–(BUSINESS WIRE)–#AFT–Novaliq GmbH, a specialty pharmaceutical company with the first water-free technology platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology, will present at the upcoming …
Objective Acuity’s Trials Confirm Visual Acuity Testing Breakthrough
AUCKLAND, New Zealand–(BUSINESS WIRE)–Digital vision company Objective Acuity set to deliver the world’s first, objective, visual acuity test. Trials show its digital technology tracks OKN
LAMEA Contact Lenses Market Review & Outlook (2018-2024): by Product, Design, Application and Country – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “LAMEA Contact Lenses Market Analysis (2018-2024)” report has been added to ResearchAndMarkets.com’s offering. The Latin America, Middle East and Africa Contact Lenses Market is expected to witness market growth of 8.7% CAG…
Children’s Hospital Los Angeles Team Identifies Developmental Stage for No. 1 Eye Tumor in Children
LOS ANGELES–(BUSINESS WIRE)–Investigators at Children’s Hospital Los Angeles have been able to pinpoint the exact stage of development of the human retina, when cells can grow out of control and form cancer-like masses. The finding could open the doo…
Second Sight Receives $1.6 Million Grant from National Institutes of Health to Support Orion Clinical Development
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision…
Visioneering Announces First International Revenues and Attendance at Myopia Conference in Australia
ATLANTA–(BUSINESS WIRE)–Visioneering Technologies (ASX: VTI) is already reporting its first international revenues from eye care practitioners in Australia.
Contact Lenses – Asia Pacific Markets (2018-2024): Analysis by Product, Design, Application and Country – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Contact Lenses Market Analysis (2018-2024)” report has been added to ResearchAndMarkets.com’s offering. The Asia Pacific Contact Lenses Market is expected to witness market growth of 9.2% CAGR during the forec…
European Contact Lenses Market Analysis (2018-2024) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “European Contact Lenses Market Analysis (2018-2024)” report has been added to ResearchAndMarkets.com’s offering. The European Contact Lenses Market is expected to witness market growth of 8.1% CAGR during the forecast peri…
Resumen: Vivior firma un acuerdo con Kochoptik para evaluar el sistema de Vivior
ZÚRICH–(BUSINESS WIRE)–Vivior ha firmado un acuerdo con Kochoptik, un minorista óptico de calidad superior con sede en Suiza. Los clientes de Kochoptik usarán el Visual Behavior Monitor, el monitor de comportamiento visual de Vivior, que hará recomen…
The North American Contact Lenses Market (2018-2024) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “North American Contact Lenses Market Analysis (2018-2024)” report has been added to ResearchAndMarkets.com’s offering. The North American Contact Lenses Market is expected to witness market growth of 6.4% CAGR during the f…
Cataract – Pipeline Insight, 2018 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Cataract – Pipeline Insight, 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report offers a comprehensive insight of the pipeline (under development) therapeutics scenario and growth prospec…
Riassunto: Vivior firma un accordo con Kochoptik per valutare il sistema di Vivior
ZURIGO–(BUSINESS WIRE)–Vivior ha firmato un accordo con Kochoptik, un negozio di ottica premium in Svizzera. I clienti di Kochoptik indosseranno Visual Behavior Monitor di Vivior, un dispositivo che fornisce suggerimenti per le soluzioni visivi perso…
Hemovent Introduces Its Highly Anticipated Next-Gen ECLS System, MOBYBOX™, At 29th Annual ELSO Conference
AACHEN, Germany–(BUSINESS WIRE)–Hemovent introduces its highly anticipated next-gen ECLS system, MOBYBOX™, at 29th Annual ELSO Conference
Vivior unterzeichnet Vereinbarung mit Kochoptik über Erprobung des Vivior-Systems
ZÜRICH–(BUSINESS WIRE)–Vivior hat eine Vereinbarung mit Kochoptik, einer führenden Optikerkette in der Schweiz, unterzeichnet. Die Kunden von Kochoptik tragen künftig den Visual Behavior Monitor von Vivior, um eine Empfehlung für eine individuelle Se…
Samenvatting: Vivior tekent overeenkomst met Kochoptik om Vivior’s systeem te evalueren
ZURICH–(BUSINESS WIRE)–Vivior heeft een overeenkomst getekend met Kochoptik, een premium opticiën in Zwitserland. Klanten van Kochoptik zullen Vivior’s Visual Behaviour Monitor gebruiken om een aanbeveling te krijgen voor een geïndividualiseerde zorg…
Vivior conclut un accord avec Kochoptik aux fins de l’évaluation du système de Vivior
ZURICH–(BUSINESS WIRE)–Vivior a signé un accord avec Kochoptik, un opticien suisse de haute qualité. Les clients de Kochoptik porteront le moniteur de comportement visuel de Vivior, ce qui conduira à une recommandation de solution individualisée de s…
Sun Pharma and SPARC Announce US FDA Approval of XELPROS™ to Treat Open-angle Glaucoma or Ocular Hypertension
MUMBAI, India & PRINCETON, N.J.–(BUSINESS WIRE)–#BAK–Sun Pharma’s XELPROS™ (latanoprost ophthalmic emulsion) 0.005% approved by the U.S. FDA